How much funding has Longboard Pharmaceuticals raised?

Longboard Pharmaceuticals has disclosed $56M raised across 1 round.

Where is Longboard Pharmaceuticals headquartered?

Longboard Pharmaceuticals is headquartered in San Diego, US.

Longboard Pharmaceuticals

San Diego, US · Founded 2020 · Delaware corporation

Longboard Pharmaceuticals is a clinical-stage biopharmaceutical company developing small-molecule medicines targeting G protein-coupled receptors for neurological diseases, with an initial focus on rare conditions. Its lead candidate, bexicaserin (LP352), is an oral 5-HT2C receptor superagonist in development for seizures associated with developmental and epileptic encephalopathies; the company is now a subsidiary of Lundbeck.

BiotechHealthtech

Founders & leadership

Laurie StelzerNamed on SEC filing

Kevin R LindNamed on SEC filing

Vincent AurentzNamed on SEC filing

Chandra LeoNamed on SEC filing

Kevin LindPresident & CEO

Randall KayeEVP & Chief Medical Officer

Brandi RobertsChief Financial Officer

Steven SpectorGeneral Counsel / Head of Business Development

Chad OrevilloHead of Clinical Operations

Reported raises · per SEC filings

Form D private placements

$56M disclosed across 1 round · 2020

▶$56MraisedNov 2020 · 17 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Laurie StelzerDirector
Kevin R LindExecutive Officer, Director
Vincent AurentzDirector
Chandra LeoDirector

Offering amount: $56M
Amount sold: $56M
First sale: Oct 2020
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

LeadIQ8 shared keywordsLeadIQ is a B2B sales prospecting platform that provides contact and account data to enrich CRMs, track buyer role changes, and automate outreach for revenue teams. It integrates with tools like Salesforce, HubSpot, Outreach, and Salesloft, and uses AI to surface high-fit accounts and personalize prospecting.

Companies competing with Longboard Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Longboard Pharmaceuticals do?: Longboard Pharmaceuticals is a clinical-stage biopharmaceutical company developing small-molecule medicines targeting G protein-coupled receptors for neurological diseases, with an initial focus on rare conditions. Its lead candidate, bexicaserin (LP352), is an oral 5-HT2C receptor superagonist in development for seizures associated with developmental and epileptic encephalopathies; the company is now a subsidiary of Lundbeck.
How much funding has Longboard Pharmaceuticals raised?: Longboard Pharmaceuticals has disclosed $56M raised across 1 round.
Where is Longboard Pharmaceuticals headquartered?: Longboard Pharmaceuticals is headquartered in San Diego, US.